Loading…
Antimicrobial susceptibility of ileal symbiont intracellularis isolated from pigs with proliferative enteropathy
Proliferative enteropathy is caused by the microaerophilic obligate intracellular bacterium ileal symbiont (IS) intracellularis. Treatment of this disease is problematic because of the lack of in vivo or in vitro data on the activities of antimicrobial agents. A new procedure for determining the sus...
Saved in:
Published in: | Journal of Clinical Microbiology 1995-05, Vol.33 (5), p.1314-1317 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c570t-8c0b10cb264eb10f3cbb42302dd606adfe684dbc5bb4144dfa526236aa0de4cf3 |
---|---|
cites | |
container_end_page | 1317 |
container_issue | 5 |
container_start_page | 1314 |
container_title | Journal of Clinical Microbiology |
container_volume | 33 |
creator | McOrist, S. (University of Edinburgh, Easter Bush, Midlothan, UK.) Mackie, R.A Lawson, G.H.K |
description | Proliferative enteropathy is caused by the microaerophilic obligate intracellular bacterium ileal symbiont (IS) intracellularis. Treatment of this disease is problematic because of the lack of in vivo or in vitro data on the activities of antimicrobial agents. A new procedure for determining the susceptibility of IS intracellularis was developed by using a tissue culture system which promotes the in vitro multiplication of this organism. Nineteen antimicrobial agents were evaluated in triplicate cultures for their intracellular and extracellular activities against up to three IS intracellularis strains isolated from pigs with proliferative enteropathy. The MIC was defined as the lowest concentration which prevented multiplication of 99% of the IS intracellularis isolates. Penicillin, erythromycin, difioxacin, virginiamycin, and chlortetracycline were the most active compounds tested, all with MICs of less than or equal to 1 microgram/ml. Tiamulin and tilmicosin were the next most active compounds, with MICs of less than or equal to 4 microgram/ml. The MICs of aminoglycosides were generally 32 microgram/ml. Both lincomycin and tylosin were relatively inactive against the IS intracellularis strains tested, with MICs of 32 and 64 microgram/ml, respectively. These results indicate that some compounds capable of intracytoplasmic accumulation and blocking bacterial protein synthesis were active against IS intracellularis strains isolated from pigs with proliferative enteropathy. The in vitro cultivation system shows promise as a method for studying the interaction between IS intracellularis and antimicrobial agents and for screening new antibiotics for use in therapy |
doi_str_mv | 10.1128/jcm.33.5.1314-1317.1995 |
format | article |
fullrecord | <record><control><sourceid>proquest_highw</sourceid><recordid>TN_cdi_highwire_asm_jcm_33_5_1314</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16761876</sourcerecordid><originalsourceid>FETCH-LOGICAL-c570t-8c0b10cb264eb10f3cbb42302dd606adfe684dbc5bb4144dfa526236aa0de4cf3</originalsourceid><addsrcrecordid>eNqFkV2L1TAQhoso63H1DwhiBfGuNR9N0l54sSx-wYIXuuBdSNPkdJa0qUm6y_n3ppzDwb3yJgkzzzuZmbco3mJUY0zaj3d6qimtWY0pbqp8iBp3HXtS7DDq2opz9PtpsUOoYxXGVDwvXsR4hxBuGsYuigvBMRON2BXL1ZxgAh18D8qVcY3aLAl6cJAOpbclOLPFD1MPfk4lzCkobZxbnQoQS4jeqWSG0gY_lQvsY_kAaSyX4B1YE1SCe1OaOZngF5XGw8vimVUumlen-7K4_fL51_W36ubH1-_XVzeVZgKlqtWox0j3hDcmPyzVfd8QisgwcMTVYA1vm6HXLIfzUINVjHBCuVJoMI229LL4dKy7rP1kBm22xp1cAkwqHKRXIB9nZhjl3t9LQlrMSNZ_OOmD_7OamOQEcRtczcavUQrRICJa_l8Q87zsVmygOIJ52TEGY8_NYCQ3U2U2VVIqmdxM3Q4hN1Oz8s2_s5x1Jxdz_v0pr6JWzgY1a4hnjDIkGMEZe3fERtiPDxCMVHF6_GlmXh8Zq7xU-2yxvP3Z8byUXOAvMV_EHg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16761876</pqid></control><display><type>article</type><title>Antimicrobial susceptibility of ileal symbiont intracellularis isolated from pigs with proliferative enteropathy</title><source>American Society for Microbiology Journals</source><source>PubMed Central</source><creator>McOrist, S. (University of Edinburgh, Easter Bush, Midlothan, UK.) ; Mackie, R.A ; Lawson, G.H.K</creator><creatorcontrib>McOrist, S. (University of Edinburgh, Easter Bush, Midlothan, UK.) ; Mackie, R.A ; Lawson, G.H.K</creatorcontrib><description>Proliferative enteropathy is caused by the microaerophilic obligate intracellular bacterium ileal symbiont (IS) intracellularis. Treatment of this disease is problematic because of the lack of in vivo or in vitro data on the activities of antimicrobial agents. A new procedure for determining the susceptibility of IS intracellularis was developed by using a tissue culture system which promotes the in vitro multiplication of this organism. Nineteen antimicrobial agents were evaluated in triplicate cultures for their intracellular and extracellular activities against up to three IS intracellularis strains isolated from pigs with proliferative enteropathy. The MIC was defined as the lowest concentration which prevented multiplication of 99% of the IS intracellularis isolates. Penicillin, erythromycin, difioxacin, virginiamycin, and chlortetracycline were the most active compounds tested, all with MICs of less than or equal to 1 microgram/ml. Tiamulin and tilmicosin were the next most active compounds, with MICs of less than or equal to 4 microgram/ml. The MICs of aminoglycosides were generally 32 microgram/ml. Both lincomycin and tylosin were relatively inactive against the IS intracellularis strains tested, with MICs of 32 and 64 microgram/ml, respectively. These results indicate that some compounds capable of intracytoplasmic accumulation and blocking bacterial protein synthesis were active against IS intracellularis strains isolated from pigs with proliferative enteropathy. The in vitro cultivation system shows promise as a method for studying the interaction between IS intracellularis and antimicrobial agents and for screening new antibiotics for use in therapy</description><identifier>ISSN: 0095-1137</identifier><identifier>EISSN: 1098-660X</identifier><identifier>DOI: 10.1128/jcm.33.5.1314-1317.1995</identifier><identifier>PMID: 7615747</identifier><identifier>CODEN: JCMIDW</identifier><language>eng</language><publisher>Washington, DC: American Society for Microbiology</publisher><subject>Animals ; Antibacterial agents ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; ANTIMICROBIANOS ; ANTIMICROBIEN ; BACTERIA ; Bacteria - drug effects ; Bacteria - isolation & purification ; Bacterial Infections - drug therapy ; Bacterial Infections - microbiology ; Bacterial Infections - veterinary ; Biological and medical sciences ; CERDO ; Drug Resistance, Microbial ; ENFERMEDADES INTESTINALES ; Enteritis - drug therapy ; Enteritis - microbiology ; Enteritis - veterinary ; Evaluation Studies as Topic ; EXPERIMENTACION IN VITRO ; EXPERIMENTATION IN VITRO ; Ileum - microbiology ; MALADIE INTESTINALE ; Medical sciences ; Microbial Sensitivity Tests ; Pharmacology. Drug treatments ; PORCIN ; Swine ; Swine Diseases - drug therapy ; Swine Diseases - microbiology</subject><ispartof>Journal of Clinical Microbiology, 1995-05, Vol.33 (5), p.1314-1317</ispartof><rights>1995 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c570t-8c0b10cb264eb10f3cbb42302dd606adfe684dbc5bb4144dfa526236aa0de4cf3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC228152/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC228152/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,3188,3189,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3507521$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7615747$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>McOrist, S. (University of Edinburgh, Easter Bush, Midlothan, UK.)</creatorcontrib><creatorcontrib>Mackie, R.A</creatorcontrib><creatorcontrib>Lawson, G.H.K</creatorcontrib><title>Antimicrobial susceptibility of ileal symbiont intracellularis isolated from pigs with proliferative enteropathy</title><title>Journal of Clinical Microbiology</title><addtitle>J Clin Microbiol</addtitle><description>Proliferative enteropathy is caused by the microaerophilic obligate intracellular bacterium ileal symbiont (IS) intracellularis. Treatment of this disease is problematic because of the lack of in vivo or in vitro data on the activities of antimicrobial agents. A new procedure for determining the susceptibility of IS intracellularis was developed by using a tissue culture system which promotes the in vitro multiplication of this organism. Nineteen antimicrobial agents were evaluated in triplicate cultures for their intracellular and extracellular activities against up to three IS intracellularis strains isolated from pigs with proliferative enteropathy. The MIC was defined as the lowest concentration which prevented multiplication of 99% of the IS intracellularis isolates. Penicillin, erythromycin, difioxacin, virginiamycin, and chlortetracycline were the most active compounds tested, all with MICs of less than or equal to 1 microgram/ml. Tiamulin and tilmicosin were the next most active compounds, with MICs of less than or equal to 4 microgram/ml. The MICs of aminoglycosides were generally 32 microgram/ml. Both lincomycin and tylosin were relatively inactive against the IS intracellularis strains tested, with MICs of 32 and 64 microgram/ml, respectively. These results indicate that some compounds capable of intracytoplasmic accumulation and blocking bacterial protein synthesis were active against IS intracellularis strains isolated from pigs with proliferative enteropathy. The in vitro cultivation system shows promise as a method for studying the interaction between IS intracellularis and antimicrobial agents and for screening new antibiotics for use in therapy</description><subject>Animals</subject><subject>Antibacterial agents</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>ANTIMICROBIANOS</subject><subject>ANTIMICROBIEN</subject><subject>BACTERIA</subject><subject>Bacteria - drug effects</subject><subject>Bacteria - isolation & purification</subject><subject>Bacterial Infections - drug therapy</subject><subject>Bacterial Infections - microbiology</subject><subject>Bacterial Infections - veterinary</subject><subject>Biological and medical sciences</subject><subject>CERDO</subject><subject>Drug Resistance, Microbial</subject><subject>ENFERMEDADES INTESTINALES</subject><subject>Enteritis - drug therapy</subject><subject>Enteritis - microbiology</subject><subject>Enteritis - veterinary</subject><subject>Evaluation Studies as Topic</subject><subject>EXPERIMENTACION IN VITRO</subject><subject>EXPERIMENTATION IN VITRO</subject><subject>Ileum - microbiology</subject><subject>MALADIE INTESTINALE</subject><subject>Medical sciences</subject><subject>Microbial Sensitivity Tests</subject><subject>Pharmacology. Drug treatments</subject><subject>PORCIN</subject><subject>Swine</subject><subject>Swine Diseases - drug therapy</subject><subject>Swine Diseases - microbiology</subject><issn>0095-1137</issn><issn>1098-660X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><recordid>eNqFkV2L1TAQhoso63H1DwhiBfGuNR9N0l54sSx-wYIXuuBdSNPkdJa0qUm6y_n3ppzDwb3yJgkzzzuZmbco3mJUY0zaj3d6qimtWY0pbqp8iBp3HXtS7DDq2opz9PtpsUOoYxXGVDwvXsR4hxBuGsYuigvBMRON2BXL1ZxgAh18D8qVcY3aLAl6cJAOpbclOLPFD1MPfk4lzCkobZxbnQoQS4jeqWSG0gY_lQvsY_kAaSyX4B1YE1SCe1OaOZngF5XGw8vimVUumlen-7K4_fL51_W36ubH1-_XVzeVZgKlqtWox0j3hDcmPyzVfd8QisgwcMTVYA1vm6HXLIfzUINVjHBCuVJoMI229LL4dKy7rP1kBm22xp1cAkwqHKRXIB9nZhjl3t9LQlrMSNZ_OOmD_7OamOQEcRtczcavUQrRICJa_l8Q87zsVmygOIJ52TEGY8_NYCQ3U2U2VVIqmdxM3Q4hN1Oz8s2_s5x1Jxdz_v0pr6JWzgY1a4hnjDIkGMEZe3fERtiPDxCMVHF6_GlmXh8Zq7xU-2yxvP3Z8byUXOAvMV_EHg</recordid><startdate>19950501</startdate><enddate>19950501</enddate><creator>McOrist, S. (University of Edinburgh, Easter Bush, Midlothan, UK.)</creator><creator>Mackie, R.A</creator><creator>Lawson, G.H.K</creator><general>American Society for Microbiology</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>C1K</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19950501</creationdate><title>Antimicrobial susceptibility of ileal symbiont intracellularis isolated from pigs with proliferative enteropathy</title><author>McOrist, S. (University of Edinburgh, Easter Bush, Midlothan, UK.) ; Mackie, R.A ; Lawson, G.H.K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c570t-8c0b10cb264eb10f3cbb42302dd606adfe684dbc5bb4144dfa526236aa0de4cf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Animals</topic><topic>Antibacterial agents</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>ANTIMICROBIANOS</topic><topic>ANTIMICROBIEN</topic><topic>BACTERIA</topic><topic>Bacteria - drug effects</topic><topic>Bacteria - isolation & purification</topic><topic>Bacterial Infections - drug therapy</topic><topic>Bacterial Infections - microbiology</topic><topic>Bacterial Infections - veterinary</topic><topic>Biological and medical sciences</topic><topic>CERDO</topic><topic>Drug Resistance, Microbial</topic><topic>ENFERMEDADES INTESTINALES</topic><topic>Enteritis - drug therapy</topic><topic>Enteritis - microbiology</topic><topic>Enteritis - veterinary</topic><topic>Evaluation Studies as Topic</topic><topic>EXPERIMENTACION IN VITRO</topic><topic>EXPERIMENTATION IN VITRO</topic><topic>Ileum - microbiology</topic><topic>MALADIE INTESTINALE</topic><topic>Medical sciences</topic><topic>Microbial Sensitivity Tests</topic><topic>Pharmacology. Drug treatments</topic><topic>PORCIN</topic><topic>Swine</topic><topic>Swine Diseases - drug therapy</topic><topic>Swine Diseases - microbiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McOrist, S. (University of Edinburgh, Easter Bush, Midlothan, UK.)</creatorcontrib><creatorcontrib>Mackie, R.A</creatorcontrib><creatorcontrib>Lawson, G.H.K</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of Clinical Microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McOrist, S. (University of Edinburgh, Easter Bush, Midlothan, UK.)</au><au>Mackie, R.A</au><au>Lawson, G.H.K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antimicrobial susceptibility of ileal symbiont intracellularis isolated from pigs with proliferative enteropathy</atitle><jtitle>Journal of Clinical Microbiology</jtitle><addtitle>J Clin Microbiol</addtitle><date>1995-05-01</date><risdate>1995</risdate><volume>33</volume><issue>5</issue><spage>1314</spage><epage>1317</epage><pages>1314-1317</pages><issn>0095-1137</issn><eissn>1098-660X</eissn><coden>JCMIDW</coden><abstract>Proliferative enteropathy is caused by the microaerophilic obligate intracellular bacterium ileal symbiont (IS) intracellularis. Treatment of this disease is problematic because of the lack of in vivo or in vitro data on the activities of antimicrobial agents. A new procedure for determining the susceptibility of IS intracellularis was developed by using a tissue culture system which promotes the in vitro multiplication of this organism. Nineteen antimicrobial agents were evaluated in triplicate cultures for their intracellular and extracellular activities against up to three IS intracellularis strains isolated from pigs with proliferative enteropathy. The MIC was defined as the lowest concentration which prevented multiplication of 99% of the IS intracellularis isolates. Penicillin, erythromycin, difioxacin, virginiamycin, and chlortetracycline were the most active compounds tested, all with MICs of less than or equal to 1 microgram/ml. Tiamulin and tilmicosin were the next most active compounds, with MICs of less than or equal to 4 microgram/ml. The MICs of aminoglycosides were generally 32 microgram/ml. Both lincomycin and tylosin were relatively inactive against the IS intracellularis strains tested, with MICs of 32 and 64 microgram/ml, respectively. These results indicate that some compounds capable of intracytoplasmic accumulation and blocking bacterial protein synthesis were active against IS intracellularis strains isolated from pigs with proliferative enteropathy. The in vitro cultivation system shows promise as a method for studying the interaction between IS intracellularis and antimicrobial agents and for screening new antibiotics for use in therapy</abstract><cop>Washington, DC</cop><pub>American Society for Microbiology</pub><pmid>7615747</pmid><doi>10.1128/jcm.33.5.1314-1317.1995</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0095-1137 |
ispartof | Journal of Clinical Microbiology, 1995-05, Vol.33 (5), p.1314-1317 |
issn | 0095-1137 1098-660X |
language | eng |
recordid | cdi_highwire_asm_jcm_33_5_1314 |
source | American Society for Microbiology Journals; PubMed Central |
subjects | Animals Antibacterial agents Antibiotics. Antiinfectious agents. Antiparasitic agents ANTIMICROBIANOS ANTIMICROBIEN BACTERIA Bacteria - drug effects Bacteria - isolation & purification Bacterial Infections - drug therapy Bacterial Infections - microbiology Bacterial Infections - veterinary Biological and medical sciences CERDO Drug Resistance, Microbial ENFERMEDADES INTESTINALES Enteritis - drug therapy Enteritis - microbiology Enteritis - veterinary Evaluation Studies as Topic EXPERIMENTACION IN VITRO EXPERIMENTATION IN VITRO Ileum - microbiology MALADIE INTESTINALE Medical sciences Microbial Sensitivity Tests Pharmacology. Drug treatments PORCIN Swine Swine Diseases - drug therapy Swine Diseases - microbiology |
title | Antimicrobial susceptibility of ileal symbiont intracellularis isolated from pigs with proliferative enteropathy |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T08%3A06%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_highw&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antimicrobial%20susceptibility%20of%20ileal%20symbiont%20intracellularis%20isolated%20from%20pigs%20with%20proliferative%20enteropathy&rft.jtitle=Journal%20of%20Clinical%20Microbiology&rft.au=McOrist,%20S.%20(University%20of%20Edinburgh,%20Easter%20Bush,%20Midlothan,%20UK.)&rft.date=1995-05-01&rft.volume=33&rft.issue=5&rft.spage=1314&rft.epage=1317&rft.pages=1314-1317&rft.issn=0095-1137&rft.eissn=1098-660X&rft.coden=JCMIDW&rft_id=info:doi/10.1128/jcm.33.5.1314-1317.1995&rft_dat=%3Cproquest_highw%3E16761876%3C/proquest_highw%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c570t-8c0b10cb264eb10f3cbb42302dd606adfe684dbc5bb4144dfa526236aa0de4cf3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=16761876&rft_id=info:pmid/7615747&rfr_iscdi=true |